SLC22A1 and cancer: The transporter of organic cation, OCT1, has been associated with the uptake of the tyrosine kinase inhibitor (TKI) sorafenib by cancer cells [46]; however, in CCA, a marked reduction in OCT1 function occurs due to a decrease in mRNA levels and the predominance of aberrant splicing variants [7,46].